Pharma given COVID-19 test ‘call to arms’ by health secretaryUK health secretary Matt Hancock has asked pharma and biotech firms to help the country find antibody tests Share XPharma given COVID-19 test ‘call to arms’ by health secretaryhttps://pharmaphorum.com/news/pharma-given-covid-19-test-call-to-arms-by-health-secretary/
FDA approves Pfizer/Merck KGaA combo in advanced colorectal cancerThe FDA has approved a combination of Pfizer’s Braftovi and Merck KGaA’s Erbitux for a form of untreated Share XFDA approves Pfizer/Merck KGaA combo in advanced colorectal cancerhttps://pharmaphorum.com/news/fda-approves-pfizer-merck-kgaa-combo-in-advanced-colorectal-cancer/
Inovio begins clinical trial of COVID-19 vaccineUS-based Inovio has become the third biotech to begin clinical development of a vaccine against the COVID-19 coronavirus. Share XInovio begins clinical trial of COVID-19 vaccinehttps://pharmaphorum.com/news/inovio-begins-clinical-trial-of-covid-19-vaccine/
Cancer Research UK cuts research funding as COVID-19 hits incomeCancer Research UK has cut funding to its research activities, as the charity faces a cut to its Share XCancer Research UK cuts research funding as COVID-19 hits incomehttps://pharmaphorum.com/news/cancer-research-uk-cuts-funding-as-covid-19-hits-income/
Pharma bad boy Shkreli asks for prison release to fight COVID-19Pharma bad boy Martin Shkreli has asked authorities to let him out of prison, saying that he could Share XPharma bad boy Shkreli asks for prison release to fight COVID-19https://pharmaphorum.com/news/pharma-bad-boy-shkreli-asks-for-prison-release-to-fight-covid-19/
GSK eyes nasal polyps use for Nucala after trial successGlaxoSmithKline is eyeing another indication for its Nucala (mepolizumab) biologic drug after a phase 3 trial in inflammation Share XGSK eyes nasal polyps use for Nucala after trial successhttps://pharmaphorum.com/news/gsk-eyes-nasal-polyps-use-for-nucala-after-trial-success/
Gilead begins UK trials of COVID-19 drug remdesivirGilead has begun testing its COVID-19 coronavirus antiviral remdesivir in the UK, announcing plans to trial the drug Share XGilead begins UK trials of COVID-19 drug remdesivirhttps://pharmaphorum.com/news/gilead-begins-uk-trials-of-covid-19-drug-remdesivir/
J&J and US government invest $1 billion in COVID-19 vaccineJohnson & Johnson has announced plans to team up with the US government to invest more than $1 Share XJ&J and US government invest $1 billion in COVID-19 vaccinehttps://pharmaphorum.com/news/jj-and-us-government-invest-1-billion-in-covid-19-vaccine/
BI opens second branch of digital lab in ChinaBoehringer Ingelheim has announced that it will open a second branch of its digital lab, BI X, in Share XBI opens second branch of digital lab in Chinahttps://pharmaphorum.com/news/bi-opens-branch-of-digital-lab-in-china/
